Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012

References

• Bedimo, R. J., Westfall, A. O., Drechsler, H., Vidiella, G., & Tebas, P. (2011). Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. Clinical Infectious Diseases, 53(1), 84–91. doi:10.1093/cid/cir269
   PubMed Web of Science ®Google Scholar
• Boccara, F., & Cohen, A. (2013). Immune activation and coronary atherosclerosis in HIV-infected women: Where are we now, and where will we go next? Journal of Infectious Diseases, 208(11), 1729–1731. doi: 10.1093/infdis/jit511
   PubMed Web of Science ®Google Scholar
• Burkhalter, J. E., Springer, C. M., Chhabra, R., Ostroff, J. S., & Rapkinm, B. D. (2005). Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine & Tobacco Research, 7(4), 511–522. doi: 10.1080/14622200500186064
   PubMed Web of Science ®Google Scholar
• DAD Study Group, Friis-Møller, N., Reiss, P., Sabin, C. A., Weber, R., D'Arminio Monforte, A., … Lundgren, J. D. (2007). Class of antiretroviral drugs and the risk of myocardial infarction. New England Journal of Medicine, 356(17), 1723–1735. doi: 10.1056/NEJMoa062744
   PubMed Web of Science ®Google Scholar
• D'Arminio, A., Sabin, C. A., Phillips, A. N., Reiss, P., Weber, R., Kirk, O., … Writing Committee of the D:A:D: Study Group. (2004). Cardio- and cerebrovascular events in HIV-infected persons. AIDS, 18(13), 1811–1817. doi: 10.1097/00002030-200409030-00010
   PubMed Web of Science ®Google Scholar
• D'Ascenzo, F., Quadri, G., Cerrato, E., Calcagno, A., Omedè, P., Grosso Marra, W., … Gaita, F. (2015). A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era. Journal of Cardiovascular Medicine, 16(12), 839–843. doi: 10.2459/JCM.0b013e328365ca31
   PubMed Web of Science ®Google Scholar
• Dolan, S. E., Hadigan, C., Killilea, K. M., Sullivan, M. P., Hemphill, L., Lees, R. S., … Grinspoon, S. (2005, May 1). Increased cardiovascular disease risk indices in HIV-infected women. JAIDS Journal of Acquired Immune Deficiency Syndromes, 39(1), 44–54. doi: 10.1097/01.qai.0000159323.59250.83
   PubMed Web of Science ®Google Scholar
• EUROCISS Working Group. (2003, September). Coronary and cerebrovascular population-based registers in Europe: Are morbidity indicators comparable? Results from the EUROCISS project. European Journal of Public Health, 13(3 Suppl.), 55–60.
   PubMedGoogle Scholar
• Ferketich, A. K., Schwartzbaum, J. A., Frid, D. J., & Moeschberger, M. L. (2000). Depression as an antecedent to heart disease among women and men in the NHANES I study. National health and nutrition examination survey. Archives of Internal Medicine, 160(9), 1261–1268. doi: 10.1001/archinte.160.9.1261
   PubMed Web of Science ®Google Scholar
• Fernández-Montero, J. V., Barreiro, P., de Mendoza, C., Labarga, P., & Soriano, V. (2016). Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients. Journal of Viral Hepatitis, 23(1), 47–52. doi:10.1111/jvh.12447
   PubMed Web of Science ®Google Scholar
• Gotti, D., Cesana, B. M., Albini, L., Calabresi, A., Izzo, I., Focà, E., … Torti, C. (2012). Increase in standard cholesterol and large HDL particle subclasses in antiretroviral-naïve patients prescribed efavirenz compared to atazanavir/ritonavir. HIV Clinical Trials, 13(5), 245–255. doi:10.1310/hct1305-245
   PubMed Web of Science ®Google Scholar
• Hatleberg, C. I., Ryom, L., El-Sadr, W., Mocroft, A., Reiss, P., de Wit, S., … Sabin, C. (2014). Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study. Journal of the International AIDS Society, 17(4 Suppl. 3), 19516.
   PubMedGoogle Scholar
• Herrett, E., Shah, A. D., Boggon, R., Denaxas, S., Smeeth, L., Van Staa, T., … Hemingway, H. (2013, May 20). Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: Cohort study. BMJ, 346, f2350. doi:10.1136/bmj.f2350
   PubMedGoogle Scholar
• Kaplan, R. C., Kingsley, L. A., Sharrett, A. R., Li, X., Lazar, J., Tien, P. C., … Gange, S. J. (2007). Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clinical Infectious Diseases, 45(8), 1074–1081. doi: 10.1086/521935
   PubMed Web of Science ®Google Scholar
• Klein, D. B., Leyden, W. A., Chao, C. R., Horberg, M. A., Towner, W. J., Hurley, L. B., … Silverberg, M. J. (2014, March). No difference in incidence of myocardial infarction for HIV+ and HIV– individuals in recent years. Poster presented at the 21st CROI Conference on Retroviruses and Opportunistic infections, Boston, MA.
   Google Scholar
• Kojic, E. M., Wang, C. C., & Cu-Uvin, S. (2007, December). HIV and menopause: A review. Journal of Women’s Health, 16(10), 1402–1411. doi: 10.1089/jwh.2007.0345
   PubMed Web of Science ®Google Scholar
• Lang, S., Mary-Krause, M., Cotte, L., Gilquin, J., Partisani, M., Simon, A., … Clinical Epidemiology Group of the French Hospital Database on HIV. (2010a). Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: A case-control study nested within the French hospital database on HIV ANRS cohort CO4. Archives of Internal Medicine, 170(14), 1228–1238. doi:10.1001/archinternmed.2010.197
   PubMedGoogle Scholar
• Lang, S., Mary-Krause, M., Cotte, L., Gilquin, J., Partisani, M., Simon, A., … French Hospital Database on HIV-ANRS CO4. (2010b). Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS, 24(8), 1228–1230. doi:10.1097/QAD.0b013e328339192f
   PubMed Web of Science ®Google Scholar
• Ledergerber, B., Furrer, H., Rickenbach, M., Lehmann, R., Elzi, L., Hirschel, B., … Swiss HIV Cohort Study. (2007). Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV cohort study. Clinical Infectious Diseases, 45(1), 111–119. doi: 10.1086/518619
   PubMed Web of Science ®Google Scholar
• Lee, S., Lee, S. H., Lee, S. J., Kim, K. H., Lee, J. E., Cho, H., … Kwak, I. S. (2016, April 27). Incidence and risk factors of hepatitis C virus infection among human immunodeficiency virus (HIV) patients in a large HIV clinic in South Korea. Korean Journal of Internal Medicine. doi:10.3904/kjim.2015.353
   Google Scholar
• Mateen, F. J., Post, W. S., Sacktor, N., Abraham, A. G., Becker, J. T., Smith, B. R., … Multicenter AIDS Cohort Study (MACS) Investigators. (2013). Long-term predictive value of the Framingham Risk Score for stroke in HIV-positive vs HIV-negative men. Neurology, 81(24), 2094–2102. doi:10.1212/01.wnl.0000437296.97946.73
   PubMed Web of Science ®Google Scholar
• Mocroft, A., Reiss, P., Gasiorowski, J., Ledergerber, B., Kowalska, J., Chiesi, A., … EuroSIDA Study Group. (2010). Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. JAIDS Journal of Acquired Immune Deficiency Syndromes, 55(2), 262–270. doi:10.1097/QAI.0b013e3181e9be6b
   PubMed Web of Science ®Google Scholar
• Mosca, L., Barrett-Connor, E., & Wenger, N. K. (2011). Sex/gender differences in cardiovascular disease prevention: What a difference a decade makes. Circulation, 124(19), 2145–2154. doi: 10.1161/CIRCULATIONAHA.110.968792
   PubMed Web of Science ®Google Scholar
• Nordell, A. D., McKenna, M., Borges, Á. H., Duprez, D., Neuhaus, J., Neaton, J. D., & INSIGHT SMART, ESPRIT Study Groups, SILCAAT Scientific Committee. (2014). Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. Journal of the American Heart Association, 3(3), e000844. doi:10.1161/JAHA.114.000844
   PubMed Web of Science ®Google Scholar
• Notiziario dell'Istituto Superiore di Sanità (ISS). (2015). vol. 28, no. 9(Suppl. 1). Retrieved from http://www.iss.it/binary/ccoa/cont/Dicembre_2015.pdf
   Google Scholar
• Obel, N., Thomsen, H. F., Kronborg, G., Larsen, C. S., Hildebrandt, P. R., Sørensen, H. T., & Gerstoft, J. (2007, June 15). Ischemic heart disease in HIV-infected and HIV-uninfected individuals: A population-based cohort study. Clinical Infectious Diseases, 44(12), 1625–1631. doi: 10.1086/518285
   PubMed Web of Science ®Google Scholar
• Ohl, J., Partisani, M., Demangeat, C., Binder-Foucard, F., Nisand, I., & Lang, J. M. (2010). Alterations of ovarian reserve tests in Human Immunodeficiency Virus (HIV)-infected women. Gynécologie Obstétrique & Fertilité, 38(5), 313–317. doi: 10.1016/j.gyobfe.2009.07.019
   PubMed Web of Science ®Google Scholar
• Pirš, M., Jug, B., Eržen, B., Šabović, M., Karner, P., Poljak, M., & Tomažič, J. (2014). Cardiovascular risk assessment in HIV-infected Male patients: a comparison of Framingham, SCORE, PROCAM and DAD risk equations. Acta Dermatovenerol Alp Pannonica Adriat, 23(3), 43–47.
   PubMedGoogle Scholar
• Remick, J., Georgiopoulou, V., Marti, C., Ofotokun, I., Kalogeropoulos, A., Lewis, W., & Butler, J. (2014). Heart failure in patients with human immunodeficiency virus infection: Epidemiology, pathophysiology, treatment, and future research. Circulation, 129(17), 1781–1789. doi:10.1161/CIRCULATIONAHA.113.004574
   PubMed Web of Science ®Google Scholar
• Reynolds, N. R. (2009, June). Cigarette smoking and HIV: More evidence for action. AIDS Education and Prevention, 21(3 Suppl.), 106–121. doi: 10.1521/aeap.2009.21.3_supp.106
   PubMed Web of Science ®Google Scholar
• Savès, M., Chêne, G., Ducimetière, P., Leport, C., Le Moal, G., Amouyel, P., … French WHO MONICA Project and the APROCO (ANRS EP11) Study Group. (2003). Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clinical Infectious Diseases, 37(2), 292–298. doi: 10.1086/375844
   PubMed Web of Science ®Google Scholar
• Shalit, P. (2014). Management of dyslipidemia in patients with human immunodeficiency virus. Reviews in Cardiovascular Medicine, 15( Suppl. 1), S38–S46.
   PubMed Web of Science ®Google Scholar
• Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. The Journal of Clinical Endocrinology & Metabolism, 92(7), 2506–2512. doi: 10.1210/jc.2006-2190
   PubMed Web of Science ®Google Scholar
• Webb, M. S., Vanable, P. A., Carey, M. P., & Blair, D. C. (2007). Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. Journal of Behavioral Medicine, 30(5), 371–383. doi: 10.1007/s10865-007-9112-9
   PubMed Web of Science ®Google Scholar
• Womack, J. A., Chang, C. C., So-Armah, K. A., Alcorn, C., Baker, J. V., Brown, S. T., … Freiberg, M. S. (2014). HIV infection and cardiovascular disease in women. Journal of the American Heart Association, 3(5), e001035. doi:10.1161/JAHA.114.001035
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). (2014). The top 10 causes of death. Undated May 2014. Retrieved from http//www.who.int/mediacentre/factsheets/fs310/en/
   Google Scholar
• World Health Organization (WHO). (2016). International classification of diseases (ICD)-10 version-2016. Retrieved from http://www.who.int/classifications/icd/en/
   Google Scholar
• Worm, S. W., Sabin, C., Weber, R., Reiss, P., El-Sadr, W., Dabis, F., … Lundgren, J. (2010). Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: The data collection on adverse events of anti-HIV drugs (D:A:D) study. The Journal of Infectious Diseases, 201(3), 318–330. doi:10.1086/649897
   PubMed Web of Science ®Google Scholar